Jordan F, Wu A
J Med Chem. 1978 Sep;21(9):877-82. doi: 10.1021/jm00207a008.
Several aspects of the stereoelectronic requirements of substrates of human erythrocytic purine nucleoside phosphorylase (E.C. 2.4.2.1) were elucidated providing the following information: (a) the N1 position cannot have a nonhydrogen substituent; (b) the 5'-OH group must be present for catalytic activity to be exhibited but is not an essential functional group for inhibitory action to be observed; (c) on the C8 position groups larger than -NH2 or -Br cannot be accommodated; (d) the syn-glycosyl conformation (i.e., 8-bromoguanosine) is acceptable but may not be an absolute requirement for phosphorolysis; (e) among nucleic base inhibitors methylation at N3, N7, or N9 vastly decreases the inhibitory properties as does a nitrogen in lieu of C-H in the 8 position. The results clearly indicate that this enzyme differs in its stereoelectronic requirements from the Escherichia coli enzyme.
对人红细胞嘌呤核苷磷酸化酶(E.C. 2.4.2.1)底物的立体电子需求的几个方面进行了阐明,得出以下信息:(a)N1位不能有非氢取代基;(b)5'-OH基团对于表现出催化活性是必需的,但对于观察到抑制作用不是必需的官能团;(c)在C8位上,不能容纳比-NH2或-Br更大的基团;(d)顺式糖基构象(即8-溴鸟苷)是可以接受的,但可能不是磷酸解的绝对要求;(e)在核酸碱基抑制剂中,N3、N7或N9位的甲基化会大大降低抑制特性,8位的氮取代C-H也是如此。结果清楚地表明,这种酶在立体电子需求方面与大肠杆菌的酶不同。